152 related articles for article (PubMed ID: 29181127)
1. Oxidative Modification of Blood Serum Proteins in Multiple Sclerosis after Interferon Beta and Melatonin Treatment.
Adamczyk-Sowa M; Galiniak S; Żyracka E; Grzesik M; Naparło K; Sowa P; Bartosz G; Sadowska-Bartosz I
Oxid Med Cell Longev; 2017; 2017():7905148. PubMed ID: 29181127
[TBL] [Abstract][Full Text] [Related]
2. Oxidative modification of serum proteins in multiple sclerosis.
Sadowska-Bartosz I; Adamczyk-Sowa M; Galiniak S; Mucha S; Pierzchala K; Bartosz G
Neurochem Int; 2013 Nov; 63(5):507-16. PubMed ID: 24036284
[TBL] [Abstract][Full Text] [Related]
3. Effect of melatonin supplementation on plasma lipid hydroperoxides, homocysteine concentration and chronic fatigue syndrome in multiple sclerosis patients treated with interferons-beta and mitoxantrone.
Adamczyk-Sowa M; Sowa P; Adamczyk J; Niedziela N; Misiolek H; Owczarek M; Zwirska-Korczala K
J Physiol Pharmacol; 2016 Apr; 67(2):235-42. PubMed ID: 27226183
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Melatonin on Serum Pro-inflammatory Cytokines and Oxidative Stress Markers in Relapsing Remitting Multiple Sclerosis.
Sánchez-López AL; Ortiz GG; Pacheco-Moises FP; Mireles-Ramírez MA; Bitzer-Quintero OK; Delgado-Lara DLC; Ramírez-Jirano LJ; Velázquez-Brizuela IE
Arch Med Res; 2018 Aug; 49(6):391-398. PubMed ID: 30595364
[TBL] [Abstract][Full Text] [Related]
5. Oxidative modification of blood serum proteins in multiple sclerosis after interferon or mitoxantrone treatment.
Sadowska-Bartosz I; Adamczyk-Sowa M; Gajewska A; Bartosz G
J Neuroimmunol; 2014 Jan; 266(1-2):67-74. PubMed ID: 24290230
[TBL] [Abstract][Full Text] [Related]
6. Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients.
Adamczyk-Sowa M; Pierzchala K; Sowa P; Polaniak R; Kukla M; Hartel M
J Physiol Pharmacol; 2014 Aug; 65(4):543-50. PubMed ID: 25179086
[TBL] [Abstract][Full Text] [Related]
7. The oxidation-reduction state of serum proteins in multiple sclerosis patients: effect of interferon beta-1b.
Lucas M; Bellido L; Dinca L; Solano F; Zayas MD; Izquierdo G
Neurochem Int; 1999 Apr; 34(4):287-9. PubMed ID: 10372915
[TBL] [Abstract][Full Text] [Related]
8. Interferon beta-1b is effective in Japanese RRMS patients: a randomized, multicenter study.
Saida T; Tashiro K; Itoyama Y; Sato T; Ohashi Y; Zhao Z;
Neurology; 2005 Feb; 64(4):621-30. PubMed ID: 15728282
[TBL] [Abstract][Full Text] [Related]
9. [Current status of interferon beta-1b in multiple sclerosis therapy].
Hartung HP
Med Klin (Munich); 2001 Sep; 96 Suppl 1():11-6. PubMed ID: 11603110
[TBL] [Abstract][Full Text] [Related]
10. The effects of interferon-beta on interleukin-10 in multiple sclerosis patients.
Ersoy E; Kuş CN; Sener U; Coker I; Zorlu Y
Eur J Neurol; 2005 Mar; 12(3):208-11. PubMed ID: 15693810
[TBL] [Abstract][Full Text] [Related]
11. Changes in Serum Ceruloplasmin Levels Based on Immunomodulatory Treatments and Melatonin Supplementation in Multiple Sclerosis Patients.
Adamczyk-Sowa M; Sowa P; Mucha S; Zostawa J; Mazur B; Owczarek M; Pierzchała K
Med Sci Monit; 2016 Jul; 22():2484-91. PubMed ID: 27420299
[TBL] [Abstract][Full Text] [Related]
12. IFN-beta1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment.
Guillemin GJ; Kerr SJ; Pemberton LA; Smith DG; Smythe GA; Armati PJ; Brew BJ
J Interferon Cytokine Res; 2001 Dec; 21(12):1097-101. PubMed ID: 11798468
[TBL] [Abstract][Full Text] [Related]
13. Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients.
Ferrarini AM; Sivieri S; Buttarello M; Facchinetti A; Perini P; Gallo P
Mult Scler; 1998 Jun; 4(3):174-7. PubMed ID: 9762669
[TBL] [Abstract][Full Text] [Related]
14. Beneficial Effect of Melatonin Alone or in Combination with Glatiramer Acetate and Interferon β-1b on Experimental Autoimmune Encephalomyelitis.
Ortíz GG; Briones-Torres AL; Benitez-King G; González-Ortíz LJ; Palacios-Magaña CV; Pacheco-Moisés FP
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807462
[TBL] [Abstract][Full Text] [Related]
15. Interferon beta for multiple sclerosis.
Connelly JF
Ann Pharmacother; 1994 May; 28(5):610-6. PubMed ID: 8069001
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies in multiple sclerosis patients before and during IFN-beta 1b treatment: are they correlated with the occurrence of autoimmune diseases?
Verdun E; Isoardo G; Oggero A; Ferrero B; Ghezzi A; Montanari E; Zaffaroni M; Durelli L;
J Interferon Cytokine Res; 2002 Feb; 22(2):245-55. PubMed ID: 11911808
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of fish oil on serum of TNF α , IL-1 β , and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b.
Ramirez-Ramirez V; Macias-Islas MA; Ortiz GG; Pacheco-Moises F; Torres-Sanchez ED; Sorto-Gomez TE; Cruz-Ramos JA; Orozco-Aviña G; Celis de la Rosa AJ
Oxid Med Cell Longev; 2013; 2013():709493. PubMed ID: 23861993
[TBL] [Abstract][Full Text] [Related]
18. The effects of long-term interferon-beta-1b treatment on cognitive functioning in multiple sclerosis: a 16-year longitudinal study.
Lacy M; Hauser M; Pliskin N; Assuras S; Valentine MO; Reder A
Mult Scler; 2013 Nov; 19(13):1765-72. PubMed ID: 23652214
[TBL] [Abstract][Full Text] [Related]
19. [The role of interferon beta in the treatment of multiple sclerosis].
Seeldrayers P
Rev Med Brux; 1999 Sep; 20(4):A264-7. PubMed ID: 10523902
[TBL] [Abstract][Full Text] [Related]
20. Interferon beta-1b inhibits reactive oxygen species production in peripheral blood monocytes of patients with relapsing-remitting multiple sclerosis.
Lucas M; Sánchez-Soliño O; Solano F; Izquierdo G
Neurochem Int; 1998 Aug; 33(2):101-2. PubMed ID: 9761453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
